Biosense Webster, Inc. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-05
What changed in the last 30 days
6 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 4 with minor changes only.
- Notable: DualSmart · Dual Energy THERMOCOOL SMARTTOUCH™ SF Catheter With TRUPULSE™ Generator in Persistent Atrial Fibrillation Recruitment opened
- Minor: FEATHER · Arrhythmia Mapping With a Multi-Electrode Mapping Catheter Primary completion pushed from Sep 30, 2026 to Feb 7, 2027
- Notable: SPECTRA-AF · Predict Atrial Fibrillation (AF) Burden · PAF and PsAF Treated With the VARIPULSE™ PFA Catheter Start date pushed from Oct 30, 2026 to Apr 14, 2027
- Minor: VP-EXTRA · VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE PRO Software · PsAF Enrollment closed, study ongoing
- Minor: PERSIGMA RCT · VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter · Persistent Atrial Fibrillation Trial sites expanded: 10 → 20 locations
- Minor: VP-CONFIRM · VARIPULSE Catheter and TRUPULSE Generator With VARIPULSE Pro Software · PAF or PsAF Enrollment closed, study ongoing
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
Active trials by phase
Not charted: 12 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Disease areas by active trials
Heart Disease (12) · Atrial Fibrillation (10)
Get alerts when Biosense Webster, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.